X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with REDINGTON (INDIA) - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs REDINGTON (INDIA) - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

REDINGTON (INDIA) 
   Change

Redington India, incorporated in 1961, commenced the operations in 1993 distributing information technology (IT) products. Now the company along with its subsidiaries is in the business of end-to-end supply chain management of IT and non- IT products... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES REDINGTON (INDIA) INDOCO REMEDIES/
REDINGTON (INDIA)
 
P/E (TTM) x 30.5 15.0 203.2% View Chart
P/BV x 3.6 2.5 146.4% View Chart
Dividend Yield % 0.6 1.3 48.3%  

Financials

 INDOCO REMEDIES   REDINGTON (INDIA)
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
REDINGTON (INDIA)
Mar-15
INDOCO REMEDIES/
REDINGTON (INDIA)
5-Yr Chart
Click to enlarge
High Rs360136 264.4%   
Low Rs249120 207.9%   
Sales per share (Unadj.) Rs119.0789.5 15.1%  
Earnings per share (Unadj.) Rs8.49.7 86.5%  
Cash flow per share (Unadj.) Rs15.210.7 141.9%  
Dividends per share (Unadj.) Rs1.601.90 84.2%  
Dividend yield (eoy) %0.51.5 35.4%  
Book value per share (Unadj.) Rs70.759.4 119.0%  
Shares outstanding (eoy) m92.15399.70 23.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.60.2 1,578.6%   
Avg P/E ratio x36.413.2 275.2%  
P/CF ratio (eoy) x20.011.9 167.8%  
Price / Book Value ratio x4.32.2 199.9%  
Dividend payout %19.119.6 97.4%   
Avg Mkt Cap Rs m28,08351,182 54.9%   
No. of employees `0006.0NA-   
Total wages/salary Rs m2,1674,677 46.3%   
Avg. sales/employee Rs Th1,817.0NM-  
Avg. wages/employee Rs Th359.0NM-  
Avg. net profit/employee Rs Th127.7NM-  
INCOME DATA
Net Sales Rs m10,968315,549 3.5%  
Other income Rs m40678 5.9%   
Total revenues Rs m11,007316,227 3.5%   
Gross profit Rs m1,5656,940 22.5%  
Depreciation Rs m633426 148.6%   
Interest Rs m621,586 3.9%   
Profit before tax Rs m9095,606 16.2%   
Minority Interest Rs m0-238 0.0%   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m0-52 0.0%   
Tax Rs m1391,450 9.6%   
Profit after tax Rs m7713,865 19.9%  
Gross profit margin %14.32.2 648.7%  
Effective tax rate %15.325.9 58.9%   
Net profit margin %7.01.2 573.7%  
BALANCE SHEET DATA
Current assets Rs m5,72580,200 7.1%   
Current liabilities Rs m5,45456,447 9.7%   
Net working cap to sales %2.57.5 32.8%  
Current ratio x1.01.4 73.9%  
Inventory Days Days6233 188.4%  
Debtors Days Days7251 140.4%  
Net fixed assets Rs m5,3072,152 246.7%   
Share capital Rs m184799 23.1%   
"Free" reserves Rs m6,33120,810 30.4%   
Net worth Rs m6,51623,742 27.4%   
Long term debt Rs m1,3231,011 130.9%   
Total assets Rs m11,97083,829 14.3%  
Interest coverage x15.64.5 345.0%   
Debt to equity ratio x0.20 477.1%  
Sales to assets ratio x0.93.8 24.3%   
Return on assets %7.06.5 107.0%  
Return on equity %11.816.3 72.7%  
Return on capital %12.427.9 44.4%  
Exports to sales %00 0.0%   
Imports to sales %04.0 0.0%   
Exports (fob) Rs mNA106 0.0%   
Imports (cif) Rs mNA12,758 0.0%   
Fx inflow Rs m4,507863 522.5%   
Fx outflow Rs m1,14113,108 8.7%   
Net fx Rs m3,366-12,245 -27.5%   
CASH FLOW
From Operations Rs m8862,568 34.5%  
From Investments Rs m-1,706-55 3,078.5%  
From Financial Activity Rs m1,316-2,249 -58.5%  
Net Cashflow Rs m497264 187.8%  

Share Holding

Indian Promoters % 59.2 0.0 -  
Foreign collaborators % 0.0 21.0 -  
Indian inst/Mut Fund % 12.5 7.5 166.7%  
FIIs % 6.0 37.3 16.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 34.1 65.7%  
Shareholders   12,805 14,740 86.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   EDELWEISS FINANCIAL  THOMAS COOK INDIA  MIC ELECTRONICS  NESCO LIMITED  REPCO HOME  



Today's Market

Indian Indices Continue to Fall, IT Sector Growth Projections, and Top Stocks in Action(Pre-Open)

On Wednesday, share markets in India opened in green but ended on a weak note. The BSE Sensex closed lower by 71 points to end the day at 33,704.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Feb 20, 2018 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS